Minimal contribution of desmethyl-gefitinib, the major human plasma metabolite of gefitinib, to epidermal growth factor receptor (EGFR)-mediated tumour growth inhibition
McKillop, D., Guy, S. P., Spence, M. P., Kendrew, J., Kemp, J. V., Bushby, N., Wood, P. G., Barnett, S., Hutchison, M.Volume:
36
Language:
english
Journal:
Xenobiotica
DOI:
10.1080/00498250500523253
Date:
January, 2006
File:
PDF, 113 KB
english, 2006